India warns Egypt companies against selling Sovaldi medicines

CAIRO: India today warned some companies in Egypt against selling Sovaldi medicines, used to treat hepatitis C, which they claim are being manufactured in India.

"It has come to our attention that certain unscrupulous elements are engaged in selling Sovaldi medicines in Egypt as genuine companies. These companies are claiming that their Sovaldi products are being produced in India," said an Indian Embassy statement.

The statement said that only seven Indian companies namely Cipla, Cadila, Hetero, Ranbaxy, Mylan Laboratories, Strides Arcolab, Sequent Scientific are licensed by US-based biopharmaceutical company Gilead Sciences to manufacture Sovaldi medicines.

Read more at:

Labels: , , ,